The CDC and U.S. Food and Drug Administration have authorized and recommended a second COVID-19 booster shot for people 50 and over and those with immunocompromising conditions.
The Parkinson’s Foundation recommends that all people with Parkinson’s disease get a booster shot to protect against COVID-19. If you have questions about timing your booster, ask your neurologist for more information.
Some important details about these recommendations include the following:
If you already had your first booster shot, you may be wondering what the experts say about whether additional boosters are effective for people with Parkinson’s disease. The Parkinson’s Foundation guidance states, “It is recommended that all people with Parkinson’s receive a booster shot.”
The organization does note, however, that some people experience fatigue following vaccinations, and that fatigue can lead to a higher risk of falls in people with Parkinson’s. Therefore, you should ensure that you rest and have sufficient support to prevent falls or other side effects following vaccination.
The CDC’s list of underlying medical conditions doesn’t explicitly list Parkinson’s as a condition that may qualify someone for a second booster shot. The list of underlying conditions includes, for example, chronic lung disease, diabetes, heart conditions, obesity, smoking or smoking history, and HIV infection.
“I got the Pfizer vaccine, all the shots, and both booster shots,” wrote one MyParkinsonsTeam member. Another said, “Got my COVID booster today!”
Talk to your doctor if you have questions about your eligibility for an additional COVID-19 vaccine dose.
Research indicates that antibody levels are likely to decrease over time, so getting booster doses at recommended intervals is necessary — even for vaccinated people who made antibodies after their initial shots.
Simply making antibodies does not always translate to complete immunity from COVID-19 infection. The findings from recent studies, however, are promising. In one study of immunocompromised people with cancer, researchers tested levels of antibodies (proteins the immune system makes to help destroy a target). In this case, the antibodies were to SARS-CoV-2 (the virus that causes COVID-19), made in response to the Moderna COVID-19 vaccine.
On average, antibodies against the coronavirus were identified after the second vaccine dose in about 90 percent of the study’s 515 participants. These results are considered a good sign that vaccines using mRNA — which include those by Moderna and Pfizer — for COVID-19 can trigger strong responses, even in people with compromised immune systems. It’s evidence that vaccines can protect people at higher risk of severe infections.
Researchers reviewing the charts of 181 people with Parkinson’s who received COVID-19 vaccinations found that just 1.1 percent of participants experienced worsening of their Parkinson’s symptoms following vaccination. However, those symptoms subsided on their own, without need for treatment, within two weeks. The study authors wrote that they encourage people with Parkinson’s to present for COVID-19 vaccinations because the benefits outweigh the risks.
According to the CDC, getting vaccinated is still the best way to protect yourself and slow the spread of the virus. If you are unvaccinated due to immunodeficiency, an autoimmune disease, or cancer treatment or because you are an organ transplant recipient, this new research should give you confidence to speak with your health care provider about when a COVID-19 vaccine would be right for you.
On MyParkinsonsTeam, the social support network for people with Parkinson’s and their loved ones, members come together to ask questions, give advice, and share their stories with others who understand.
Are you considering getting a second booster shot? Have you discussed any concerns with your health care provider? Share your insights in the comments below, or start a conversation by posting on your Activities page.